RecruitingNot ApplicableNCT06650995

AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure


Sponsor

Technical University of Munich

Enrollment

40 participants

Start Date

Feb 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The investigators analyze the impact of exercise and ablation in patients with symptomatic short-persistent atrial fibrillation (Afib) and heart failure with preserved ejection fraction (HFpEF). It is hypothesized that the combination of ablation and exercise better improves peak oxygen consumption (VO2peak) through improvement of peripheral (exercise training) and central (ablation) adaptations. Exercise intervention will contain a 12-week combined, video-based, supervised, endurance, resistance and respiratory training.


Eligibility

Min Age: 18 YearsMax Age: 99 Years

Inclusion Criteria2

  • Diagnosed heart failure with preserved ejection fraction
  • Symptomatic short-persistent atrial fibrillation (diagnosis within 1 year of study inclusion)

Exclusion Criteria8

  • Paroxysmal, long-persistent or permanent atrial fibrillation
  • Clinically unstable coronary artery disease or acute coronary syndrome
  • Physical and/or mental inability to perform exercise testing
  • Prior ablation therapy
  • Precapillary pulmonary hypertension at rest
  • Intracardiac shunts
  • Left ventricular ejection fraction \<50%
  • High-degree valve insufficiency or stenosis (greater than grade 1 at rest)

Interventions

OTHERExercise training

exercise intervention will consist of supervised, home-based, combined training with elements of endurance, resistance and respiratory training


Locations(1)

Department of Medicine, Division of Prevention and Sports Medicine TU Munich

Munich, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06650995


Related Trials